» Articles » PMID: 39488713

Zéro Allergie Research Clinic: a Clinical and Research Initiative in Oral Immunotherapy for Managing IgE-mediated Food Allergy

Abstract

Background And Methods: The Zéro allergie research clinic (Saguenay, Canada) is a clinical and research initiative in oral immunotherapy (OIT) for managing IgE-mediated food allergy (FA). A total of 183 children with FA and 27 non-allergic siblings were recruited to date in the Zéro allergie cohort (ZAC) to better understand biological mechanisms underlying FA and OIT prognosis. The primary aims are to (a) better understand the genetic, epigenetic, transcriptomic, metabolomic, and microbial diversity associated with FA; (b) establish the multi-omics and microbial diversity profiles of children following OIT to identify predictive prognosis biomarkers, (c) make OIT more accessible to the population of the Saguenay-Lac-Saint-Jean region, and (d) build a biobank of data and biological material.

Results: The ZAC constitutes a unique and rich biobank of biological samples (blood, buccal swabs, microbiota samples [intestinal, buccal, nasal, and cutaneous]) combined with clinical data and more than 75 phenotypic characteristics.

Conclusions: This represents an innovative interdisciplinary initiative by researchers, allergists, and paediatricians to make FA care accessible to a greater number of children with IgE-mediated FA. Ultimately, it will contribute to provide more accessible treatment options with greater chances of success through a better understanding of the biological nature of FA and OIT.

References
1.
Heinzerling L, Mari A, Bergmann K, Bresciani M, Burbach G, Darsow U . The skin prick test - European standards. Clin Transl Allergy. 2013; 3(1):3. PMC: 3565910. DOI: 10.1186/2045-7022-3-3. View

2.
Kazmi W, Berin M . Oral tolerance and oral immunotherapy for food allergy: Evidence for common mechanisms?. Cell Immunol. 2022; 383:104650. DOI: 10.1016/j.cellimm.2022.104650. View

3.
Brough H, Nadeau K, Sindher S, Alkotob S, Chan S, Bahnson H . Epicutaneous sensitization in the development of food allergy: What is the evidence and how can this be prevented?. Allergy. 2020; 75(9):2185-2205. PMC: 7494573. DOI: 10.1111/all.14304. View

4.
Lieberman J, Gupta R, Knibb R, Haselkorn T, Tilles S, Mack D . The global burden of illness of peanut allergy: A comprehensive literature review. Allergy. 2020; 76(5):1367-1384. PMC: 8247890. DOI: 10.1111/all.14666. View

5.
Johansson E, Mersha T . Genetics of Food Allergy. Immunol Allergy Clin North Am. 2021; 41(2):301-319. PMC: 8053212. DOI: 10.1016/j.iac.2021.01.010. View